Fully human hybridoma fusion partner cell lines

Details for Australian Patent Application No. 2006346496 (hide)

Owner Columbia University

Inventors Kalantarov, Gavreel; Trakht, Ilya

Agent Spruson & Ferguson

Pub. Number AU-A-2006346496

PCT Pub. Number WO2008/013552

Priority 60/711,819 26.08.05 US

Filing date 25 August 2006

Wipo publication date 31 January 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/82 (2006.01) Peptides having more than 20 amino acids - Translation products from oncogenes

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2008/013552 Priority application(s): WO2008/013552

24 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006346500-Side-by-side ATV

2006346493-Polypeptide films and methods